FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

14 results

farxiga
(DAPAGLIFLOZIN)
AstraZeneca Pharmaceuticals LP
Usage: FARXIGA (dapagliflozin) is indicated for reducing risks associated with chronic kidney disease, heart failure, and for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes or specific kidney conditions.
ferrlecit
(sodium ferric gluconate complex)
sanofi-aventis U.S. LLC
Usage: Ferrlecit is indicated for treating iron deficiency anemia in adults and pediatric patients aged 6 and older with chronic kidney disease undergoing hemodialysis and receiving supplemental epoetin therapy.
furoscix
(furosemide injection 80 mg/ 10 mL)
scPharmaceuticals Inc.
Usage: FUROSCIX is indicated for treating edema in adults with chronic heart failure or chronic kidney disease (CKD), including those with nephrotic syndrome.
injectafer
(Ferric Carboxymaltose Injection)
American Regent, Inc.
Usage: Injectafer is indicated for treating iron deficiency anemia in patients aged 1 year and older with oral iron intolerance or unsatisfactory response, and in non-dialysis dependent chronic kidney disease. It also treats iron deficiency in adults with heart failure (NYHA class II/III) to improve exercise capacity.
kerendia
(finerenone)
Bayer Healthcare Pharmaceuticals Inc.
Usage: Kerendia is indicated for reducing the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.
ozempic
(semaglutide)
Novo Nordisk
Usage: OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events and helps in preventing kidney disease progression in patients with type 2 diabetes and chronic kidney disease.
renvela
(SEVELAMER CARBONATE)
Genzyme Corporation
Usage: Renvela (sevelamer carbonate) is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) who are on dialysis.
sevelamer carbonate
(SEVELAMER CARBONATE)
Shandong Xinhua Pharmaceutical Co., Ltd.
Usage: Sevelamer carbonate tablets are indicated for controlling serum phosphorus levels in adults and children aged 6 years and older with chronic kidney disease (CKD) who are undergoing dialysis.
sevelamer carbonate
(Sevelamer Carbonate)
Winthrop U.S, a business of sanofi-aventis U.S. LLC
Usage: Sevelamer carbonate is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) undergoing dialysis.
sevelamer hydrochloride
(Sevelamer Hydrochloride)
Winthrop U.S, a business of sanofi-aventis U.S. LLC
Usage: Sevelamer hydrochloride is indicated for controlling serum phosphorus levels in patients with chronic kidney disease (CKD) undergoing dialysis. Its safety and efficacy in CKD patients not on dialysis have not been evaluated.

Medications for Chronic Kidney Diseases

farxiga

ferrlecit

furoscix

injectafer

kerendia

ozempic

renvela

sevelamer carbonate

sevelamer carbonate

sevelamer hydrochloride